Alzheimer's Disease Trial, By Invitation NCT06940687 Sponsor: Yale University Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, By Invitation

NCT06940687
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who score between 0.5 and 2 on a standard scale used to measure dementia severity (called the Clinical Dementia Rating scale).
  • People who have been diagnosed with early Alzheimer's Disease, mild dementia, or mild cognitive impairment (MCI), or people who are a caregiver to someone with one of these diagnoses.
  • People who are able to give their own consent to take part in the study.
  • People who are willing to wear a brainwave-monitoring headset (EEG) and a heart rate monitor during the study.
  • People who are willing to have small patches of body or facial hair shaved if needed to help the heart rate monitoring devices work properly.
  • People who are willing to answer survey questions related to the study topics.
  • People who are willing to be recorded by audio and/or video during the study.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who score below 0.5 or above 2 on the Clinical Dementia Rating scale.
  • People who are not able to give their own consent to take part.
  • People who are currently experiencing thoughts of suicide, self-harm, or harming others above a level defined in the study's safety plan (confirm with trial site).
  • People who are currently taking part in another clinical trial for Alzheimer's Disease or dementia.
  • People who have started a new prescription medication within the last 6 months.
  • People who have been prescribed benzodiazepines (a type of medication sometimes used for anxiety or sleep) on an as-needed basis.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

If you need support right now

This page includes language about suicide and self-harm, because that is how the trial's eligibility criteria are written. If reading it has been hard, you do not have to keep going. The services below are free, confidential, and answered by people trained for exactly this.

If you or someone else is in immediate danger, call 000.

  • Lifeline — 24/7 crisis support: 13 11 14
  • Suicide Call Back Service — 24/7 counselling: 1300 659 467
  • 13YARN — 24/7, for Aboriginal and Torres Strait Islander people: 13 92 76
  • Beyond Blue — 24/7 mental health support: 1300 22 4636
  • Emergency: 000

Outside Australia? The numbers above are Australian and will not work from overseas. Find a Helpline is a free directory of crisis lines in over 130 countries, run by ThroughLine with the International Association for Suicide Prevention. If you are in immediate danger, call your local emergency number.

Voxsanity is not a crisis service, and nothing on this page is medical advice. More Australian services are listed on our support lines page.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
28 January 2025
Est. completion
22 March 2026

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in EEG activity during live music vs pre-recorded music conditions; motion capture; facial action units; eye gaze; Changes in Standard Deviation of Normal-to-Normal (SDNN) Interval via electrocardiography (ECG, EKG).; Changes in Root Mean Square of Successive Differences (RMSSD) via electrocardiography (ECG, EKG).; Changes in Very low frequency (VLF) via electrocardiography (ECG, EKG).; Changes in the ratio of low frequency and high frequency (LF/HF) via electrocardiography (ECG, EKG).

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov